Case report reveals chemotherapy improves muscle symptoms in sporadic myopathy linked to monoclonal gammopathy.
Sporadic late-onset nemaline myopathy (SLONM) is a rare, acquired myopathy that is frequently associated with monoclonal gammopathy, most commonly monoclonal gammopathy of undetermined significance (MGUS). However, its association with overt multiple myeloma (MM) has been rarely reported. We present a case of SLONM associated with MM in which chemotherapy targeting the underlying MM led to mild-to-moderate improvement in muscle symptoms. This case underscores the potential pathogenic role of MM in SLONM and highlights the importance of treating underlying hematologic malignancies.
No takes yet. Share an insight, caveat, or question.
FURUKAWA et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: